Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3893 | 1813 | 49.2 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TAT | Author keyword | 51 | 22% | 11% | 203 |
2 | TAT PROTEIN | Author keyword | 34 | 55% | 2% | 43 |
3 | TAR RNA | Author keyword | 16 | 54% | 1% | 20 |
4 | TAT TAR INTERACTION | Author keyword | 13 | 80% | 0% | 8 |
5 | ANTI TAT ANTIBODY | Author keyword | 9 | 83% | 0% | 5 |
6 | HIV 1 TAT | Author keyword | 9 | 23% | 2% | 34 |
7 | HIV 1 TAT PROTEIN | Author keyword | 5 | 44% | 0% | 8 |
8 | CHAIR GEN PATHOL IMMUNOL | Address | 4 | 75% | 0% | 3 |
9 | TAT TOXOID | Author keyword | 4 | 75% | 0% | 3 |
10 | CORE VIROL IMMUNOL | Address | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TAT | 51 | 22% | 11% | 203 | Search TAT | Search TAT |
2 | TAT PROTEIN | 34 | 55% | 2% | 43 | Search TAT+PROTEIN | Search TAT+PROTEIN |
3 | TAR RNA | 16 | 54% | 1% | 20 | Search TAR+RNA | Search TAR+RNA |
4 | TAT TAR INTERACTION | 13 | 80% | 0% | 8 | Search TAT+TAR+INTERACTION | Search TAT+TAR+INTERACTION |
5 | ANTI TAT ANTIBODY | 9 | 83% | 0% | 5 | Search ANTI+TAT+ANTIBODY | Search ANTI+TAT+ANTIBODY |
6 | HIV 1 TAT | 9 | 23% | 2% | 34 | Search HIV+1+TAT | Search HIV+1+TAT |
7 | HIV 1 TAT PROTEIN | 5 | 44% | 0% | 8 | Search HIV+1+TAT+PROTEIN | Search HIV+1+TAT+PROTEIN |
8 | TAT TOXOID | 4 | 75% | 0% | 3 | Search TAT+TOXOID | Search TAT+TOXOID |
9 | HIV 1 LTR SEQUENCES | 3 | 100% | 0% | 3 | Search HIV+1+LTR+SEQUENCES | Search HIV+1+LTR+SEQUENCES |
10 | RNA DECOYS | 3 | 100% | 0% | 3 | Search RNA+DECOYS | Search RNA+DECOYS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANS ACTIVATOR GENE | 80 | 53% | 6% | 107 |
2 | LONG TERMINAL REPEAT | 79 | 14% | 29% | 523 |
3 | TYPE 1 TAT | 65 | 62% | 4% | 67 |
4 | ACTIVATION RESPONSIVE REGION | 59 | 84% | 2% | 32 |
5 | LOOP SEQUENCE | 57 | 79% | 2% | 37 |
6 | HIV 1 TAT | 57 | 25% | 11% | 194 |
7 | RESPONSIVE SEQUENCE | 27 | 76% | 1% | 19 |
8 | TRANS ACTIVATION | 27 | 16% | 8% | 148 |
9 | TRANSACTIVATING REGION | 18 | 83% | 1% | 10 |
10 | RESPONSIVE REGION | 17 | 54% | 1% | 22 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CONTROL OF RNA INITIATION AND ELONGATION AT THE HIV-1 PROMOTER | 1994 | 490 | 184 | 67% |
Tackling Tat | 1999 | 294 | 145 | 63% |
Multifaceted activities of the HIV-1 transactivator of transcription, Tat | 1999 | 251 | 86 | 69% |
Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection | 2004 | 67 | 103 | 75% |
The Ins and Outs of HIV-1 Tat | 2012 | 36 | 83 | 34% |
Functions of Tat: the versatile protein of human immunodeficiency virus type 1 | 2010 | 59 | 102 | 30% |
Tat gets the "green" light on transcription initiation | 2005 | 89 | 64 | 47% |
What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? | 2009 | 37 | 113 | 44% |
Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA | 1999 | 105 | 84 | 73% |
DOES HIV-1 TAT INDUCE A CHANGE IN VIRAL INITIATION RIGHTS | 1993 | 168 | 15 | 93% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHAIR GEN PATHOL IMMUNOL | 4 | 75% | 0.2% | 3 |
2 | CORE VIROL IMMUNOL | 3 | 100% | 0.2% | 3 |
3 | EA 3038 | 3 | 50% | 0.2% | 4 |
4 | IMMUNOPHARMACOL SECT | 3 | 60% | 0.2% | 3 |
5 | EMI 03 34 | 2 | 67% | 0.1% | 2 |
6 | MOL REGULAT SECT | 2 | 67% | 0.1% | 2 |
7 | SAN GALLICANO HOSP | 2 | 67% | 0.1% | 2 |
8 | THEREXSYS LTD | 2 | 67% | 0.1% | 2 |
9 | UMR CNRS UNSA 6001 | 2 | 67% | 0.1% | 2 |
10 | UNITE CANCEROL EXPT | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000225910 | REV//RRE//REV PROTEIN |
2 | 0.0000126060 | P TEFB//CDK9//HEXIM1 |
3 | 0.0000093438 | SERV REG MALAD INFECT//EQUIPE INTERFERON CYTOKINES//PHARMA NEW TECHNOL |
4 | 0.0000080200 | HIV LATENCY//HIV CURE//HIV 1 LATENCY |
5 | 0.0000075855 | EMI U 9922//UNITE PHYSIOPATHOL INFECT LENTIVIRALES//DIPARTIMENTO IGIENE MED PREVENT SANITA PUBBL |
6 | 0.0000070717 | NEF//HIV 1 NEF//HIV NEF |
7 | 0.0000070284 | BOVINE IMMUNODEFICIENCY VIRUS//EIAV//JEMBRANA DISEASE VIRUS |
8 | 0.0000056392 | HIV 1 GP41//GP120 CD4 INTERACTION//CD4 RECEPTOR |
9 | 0.0000054799 | AMINOGLYCOSIDE//AMINOGLYCOSIDES//RNA RECOGNITION |
10 | 0.0000054690 | RNA DIMERIZATION//NCP7//HIV 1 NUCLEOCAPSID PROTEIN |